Adagene finance executive reports initial holdings
Adagene Inc. executive director of finance Gu Chunfang filed an initial Form 3 showing existing equity interests in the company.
Rhea-AI Filing Summary
Adagene Inc. executive director of finance Gu Chunfang filed an initial Form 3 showing existing equity interests in the company. The filing lists direct holdings of stock options over multiple blocks of Ordinary Shares, with exercise prices ranging from 1.04 to 5.60 per share and expirations between 2029 and 2036. Gu also holds 7,045 Ordinary Shares directly and 23,438 Restricted Stock Units under the Adagene Inc. 2021 Performance Incentive Plan. According to the vesting schedule, 7,813 RSUs are scheduled to vest on each of 7/23/2026, 7/23/2027, and 7/23/2028, while several option grants are already fully vested and exercisable.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
GU CHUNFANG
Role
Executive Director of Finance
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Incentive Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Incentive Stock Option (Right to Buy) — 30,000 contracts (Direct);
Nonqualified Stock Option (Right to Buy) — 236,119 contracts (Direct);
Ordinary Shares — 7,045 shares (Direct);
Restricted Stock Unit — 23,438 shares (Direct)
Footnotes (11)
- F1. 23,438 of Restricted Stock Units ("RSUs") granted under the Adagene Inc. 2021 Performance Incentive Plan. 7,813 of RSUs shall vest on each of the following dates: 7/23/2026, 7/23/2027, and 7/23/2028.
- F2. 30,000 of time-based incentive stock option granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
- F3. 30,000 of time-based incentive stock option granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
- F4. 20,000 of performance-based incentive stock options granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
- F5. 1,250 of performance-based stock options granted under the Adagene Inc. 2021 Performance Incentive Plan, and all such option are fully vested and exercisable.
- F6. 20,000 of time-based stock option granted on 5/3/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 10,000 shares subject to this option are vested and exercisable.
- F7. 20,000 of time-based stock option granted on 12/27/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 10,000 shares subject to this option are vested and exercisable.
- F8. 19,869 of time-based stock option granted on 11/17/2024 under the Adagene Inc. 2021 Performance Incentive Plan. 50% of the options shall vest on 6/30/2025 and 6/30/2026, respectively, accordingly, 9,935 shares subject to this option are vested and exercisable.
- F9. 30,000 of time-based stock option granted on 12/24/2024 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 7,500 shares subject to this option are vested and exercisable.
- F10. 55,000 of time-based stock option granted on 6/5/2025 under the Adagene Inc. 2021 Performance Incentive Plan. The options become exercisable with respect to 25% of the shares on each of the first four anniversaries of the grant date.
- F11. 40,000 of time-based stock option granted on 2/5/2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options become exercisable with respect to 25% of the shares on each of the first four anniversaries of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Adagene (ADAG) Form 3 disclose about Gu Chunfang?
The Form 3 shows Gu Chunfang’s existing equity holdings in Adagene Inc. It lists multiple stock option grants over Ordinary Shares, directly held Ordinary Shares, and Restricted Stock Units, providing a baseline view of her compensation-linked ownership position as an officer.
What stock options are reported for Gu Chunfang in Adagene’s Form 3?
The filing lists several Incentive and Nonqualified Stock Options over Ordinary Shares. Exercise prices range from 1.04 to 5.60 per share, with expiration dates extending from 2029 through 2036, reflecting long-dated equity incentives.
How many Restricted Stock Units does Gu Chunfang hold in Adagene (ADAG)?
Gu Chunfang holds 23,438 Restricted Stock Units under Adagene’s 2021 Performance Incentive Plan. Footnotes state that 7,813 RSUs are scheduled to vest on each of 7/23/2026, 7/23/2027, and 7/23/2028, subject to the plan’s terms.
Are Gu Chunfang’s Adagene stock options already vested and exercisable?
Several of Gu Chunfang’s option grants are fully vested and exercisable. Footnotes describe fully vested time-based and performance-based options under pre-IPO and 2021 plans, while more recent time-based grants vest in 25% annual installments over four years from their grant dates.
Does this Adagene Form 3 show any recent insider buying or selling?
The Form 3 functions as an initial statement of beneficial ownership. The provided data categorize entries as holdings, with no open-market buy or sell transactions identified, instead detailing existing options, RSUs, and directly owned Ordinary Shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
